Follow
Thomas A. Munro
Thomas A. Munro
Unknown affiliation
Verified email at munro.com - Homepage
Title
Cited by
Cited by
Year
Sci-Hub provides access to nearly all scholarly literature
DS Himmelstein, AR Romero, JG Levernier, TA Munro, SR McLaughlin, ...
eLife 7, e32822, 2018
2482018
Studies toward the pharmacophore of salvinorin A, a potent κ opioid receptor agonist
TA Munro, MA Rizzacasa, BL Roth, BA Toth, F Yan
Journal of Medicinal Chemistry 48 (2), 345-348, 2005
1502005
Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A
TA Munro, MA Rizzacasa
Journal of Natural Products 66 (5), 703-705, 2003
1152003
Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum
AK Bigham, TA Munro, MA Rizzacasa, RM Robins-Browne
Journal of Natural Products 66 (9), 1242-1244, 2003
1012003
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
TA Munro, LM Berry, AV Veer, C Béguin, FI Carroll, Z Zhao, WA Carlezon, ...
BMC Pharmacology 12, 5, 2012
972012
Functional selectivity of 6′-guanidinonaltrindole (6′-GNTI) at κ-opioid receptors in striatal neurons
CL Schmid, JM Streicher, CE Groer, TA Munro, L Zhou, LM Bohn
Journal of Biological Chemistry 288 (31), 22,387-22,398, 2013
922013
Standard protecting groups create potent and selective κ opioids: salvinorin B alkoxymethyl ethers
TA Munro, KK Duncan, W Xu, Y Wang, LY Liu-Chen, WA Carlezon Jr, ...
Bioorganic & Medicinal Chemistry 16 (3), 1279-1286, 2008
812008
N-methylacetamide analog of salvinorin A: A highly potent and selective κ-opioid receptor agonist with oral efficacy
C Beguin, DN Potter, JA DiNieri, TA Munro, MR Richards, TA Paine, ...
Journal of Pharmacology and Experimental Therapeutics 324 (1), 188-195, 2008
582008
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial
JE Mendelson, JR Coyle, JC Lopez, MJ Baggott, K Flower, ET Everhart, ...
Psychopharmacology 214 (4), 933-939, 2011
472011
Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence
JM Hooker, TA Munro, C Béguin, D Alexoff, C Shea, Y Xu, BM Cohen
Neuropharmacology 57 (4), 386-391, 2009
452009
Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor
C Béguin, KK Duncan, TA Munro, DM Ho, W Xu, LY Liu-Chen, ...
Bioorganic & Medicinal Chemistry 17 (3), 1370-1380, 2009
422009
Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters
TA Munro, XP Huang, C Inglese, MG Perrone, A Van’t Veer, FI Carroll, ...
PLoS ONE 8 (8), e70701, 2013
352013
8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor
T Munro, K Duncan, R Staples, W Xu, LY Liu-Chen, C Béguin, ...
Beilstein Journal of Organic Chemistry 3, 1, 2007
282007
Autoxidation of salvinorin A under basic conditions
TA Munro, GW Goetchius, BL Roth, TA Vortherms, MA Rizzacasa
Journal of Organic Chemistry 70 (24), 10,057-10,061, 2005
242005
The chemistry of Salvia divinorum
TA Munro
Dissertation Abstracts International, 2006
182006
Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity
TA Munro, W Xu, DM Ho, LY Liu-Chen, BM Cohen
Beilstein Journal of Organic Chemistry 9, 2916–2924, 2013
132013
Salvinorin derivatives and uses thereof
C Beguin, JS Potuzak, TA Munro, KK Duncan, WA Carlezon, BM Cohen, ...
US Patent 8,492,564, 2013
82013
Salvinorin B methoxymethyl ether
TA Munro, DM Ho, BM Cohen
Acta Crystallographica Section E 68 (11), o3225-o3226, 2012
32012
Revised (β-phenyl) stereochemistry of ultrapotent μ opioid BU72
TA Munro
bioRxiv, http://doi.org/dq7s, 2020
12020
Confirmation of the NMR assignments of salvinorin A [letter to the editor]
TA Munro
Magnetic Resonance in Chemistry 45 (9), 801-801, 2007
1*2007
The system can't perform the operation now. Try again later.
Articles 1–20